Quick Answer
China SXT Pharmaceuticals, Inc. reported Stockholders Equity of $15.44 million for the year ending 2025.
- China SXT Pharmaceuticals, Inc. showed an increase of +10.8% in Stockholders Equity from 2024 to 2025.
- This data is from China SXT Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), China SXT Pharmaceuticals, Inc.'s Stockholders Equity has grown by 1,978.7%.
- Historical annual values: Fiscal year 2025: $15.44 million | Fiscal year 2024: $13.93 million | Fiscal year 2023: $14.69 million | Fiscal year 2022: $16.08 million | Fiscal year 2021: $15.96 million | Fiscal year 2020: $9.40 million | Fiscal year 2019: $11.11 million | Fiscal year 2018: $3.29 million | Fiscal year 2017: $1.85 million | Fiscal year 2016: $742.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: